arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Chemours Co

CC
$14.97 ▲ +0.44 (+2.99%) at close
Materials ·Chemicals & Allied Products ·USChemicals & Allied Products
51 Visible periods
30 Metrics
Peer-ranked Benchmarks
Price Chart
12
Health
Poor
Bearish
auto_awesome

Analytical Summary

Chemours Co faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $2.3B
Dividend Yield 0.58%
Revenue Growth -1.5%
Op. Margin
ROIC
FCF / Share $0.75
Trailing P/E
Price / Book
FCF Yield 5.0%
Debt / Equity -78.33
info Valuation on last close. End-of-day price, Sep 22, 2026.

51-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$1.59B
↓ -1.5%
Net Income Profit after all expenses
$-274.00M
↑ +28.1%
FCF / Share Free cash flow per share
$0.75
↑ +222.2%
Long-Term Debt Long-term obligations
$3.84B
↓ -6.4%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Debt to EquityDebt to Equity is concerning (bottom quartile)
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
24
Returns
5
Financial Health
2
Cash Quality
18

Dividend History

Dividend / share · sourced from SEC filings
$0.51 Latest / share
-48.8% YoY
-1.2% 11-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 13 years · 51 quarters